Indivior (LON:INDV) Sets New 52-Week High at $145,300.00

Indivior PLC (LON:INDVGet Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as £1,453 ($1,794.71) and last traded at GBX 1,425 ($17.60), with a volume of 782614 shares trading hands. The stock had previously closed at GBX 1,514 ($18.70).

Indivior Price Performance

The firm has a market capitalization of £1.94 billion, a P/E ratio of 146,400.00, a price-to-earnings-growth ratio of -5.57 and a beta of -0.05. The firm has a 50 day moving average price of GBX 1,618.62 and a 200-day moving average price of GBX 1,443.10. The company has a current ratio of 0.97, a quick ratio of 1.52 and a debt-to-equity ratio of 240.17.

Insider Activity

In other news, insider Mark Crossley sold 15,444 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of GBX 1,644 ($20.31), for a total value of £253,899.36 ($313,610.87). Corporate insiders own 3.21% of the company’s stock.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read More

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.